NICardipine for Fast Achievement of Systolic BP Targets in ICH
Key facts
- Where
- Aarhus, DenmarkSee the site
- Phase
- Phase 4
Where in Denmark
- Aarhus University HospitalAarhus, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aarhus University Hospital
- Trial code
- NCT07044232
- Record updated
- 24 June 2026
- Original description
Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP <140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, and healthcare resource utilization.Read full original descriptionShow less
NICardipine for Fast Achievement of Systolic BP Targets in ICH - a Quasi-randomized, Implementation Trial With Stepwise Rollout of Nicardipin Based Treatment of Hypertension.
Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP <140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, and healthcare resource utilization.
Inclusion: Age ≥18 years; Acute spontaneous Intracerberal Hemorrhage confirmed by imaging; Symptom onset to stroke center admission <6 hours; Elevated systolic blood pressure (>140 mmHg) at admission.
Exclusion: Presumed fatal bleeding at admission; Secondary causes of ICH (e.g., trauma, vascular malformation); Short remaining life expectancy (<12 month).